Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
Get full text
Journal Article
Book Review
The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
Clémenson, Céline, Chargari, Cyrus, Liu, Winchygn, Mondini, Michele, Ferté, Charles, Burbridge, Mike F, Cattan, Valérie, Jacquet-Bescond, Anne, Deutsch, Eric
Published in Molecular cancer therapeutics (01.10.2017)
Published in Molecular cancer therapeutics (01.10.2017)
Get full text
Journal Article
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models
Guffanti, Federica, Chilà, Rosaria, Bello, Ezia, Zucchetti, Massimo, Zangarini, Monique, Ceriani, Laura, Ferrari, Mariella, Lupi, Monica, Jacquet-Bescond, Anne, Burbridge, Mike F, Pierrat, Marie-Jeanne, Damia, Giovanna
Published in Neoplasia (New York, N.Y.) (01.01.2017)
Published in Neoplasia (New York, N.Y.) (01.01.2017)
Get full text
Journal Article
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab
Burbridge, Mike F, Bossard, Céline J, Saunier, Carine, Fejes, Imre, Bruno, Alain, Léonce, Stéphane, Ferry, Gilles, Da Violante, Georges, Bouzom, François, Cattan, Valérie, Jacquet-Bescond, Anne, Comoglio, Paolo M, Lockhart, Brian P, Boutin, Jean A, Cordi, Alex, Ortuno, Jean-Claude, Pierré, Alain, Hickman, John A, Cruzalegui, Francisco H, Depil, Stéphane
Published in Molecular cancer therapeutics (01.09.2013)
Published in Molecular cancer therapeutics (01.09.2013)
Get full text
Journal Article
Modeling restoration of gefitinib efficacy by co‐administration of MET inhibitors in an EGFR inhibitor‐resistant NSCLC xenograft model: A tumor‐in‐host DEB‐based approach
Tosca, Elena M., Gauderat, Glenn, Fouliard, Sylvain, Burbridge, Mike, Chenel, Marylore, Magni, Paolo
Published in CPT: pharmacometrics and systems pharmacology (01.11.2021)
Published in CPT: pharmacometrics and systems pharmacology (01.11.2021)
Get full text
Journal Article
CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment
Abecassis, Audrey, Roders, Nathalie, Fayon, Maxime, Choisy, Caroline, Nelson, Elisabeth, Harel, Stephanie, Royer, Bruno, Villesuzanne, Camille, Talbot, Alexis, Garrick, David, Goodhardt, Michele, Fermand, Jean‐Paul, Burbridge, Mike, Arnulf, Bertrand, Bories, Jean‐Christophe
Published in EJHaem (01.08.2022)
Published in EJHaem (01.08.2022)
Get full text
Journal Article
Only a subset of Met-activated pathways are required to sustain oncogene addiction
Bertotti, Andrea, Burbridge, Mike F, Gastaldi, Stefania, Galimi, Francesco, Torti, Davide, Medico, Enzo, Giordano, Silvia, Corso, Simona, Rolland-Valognes, Gaëlle, Lockhart, Brian P, Hickman, John A, Comoglio, Paolo M, Trusolino, Livio
Published in Science signaling (08.12.2009)
Published in Science signaling (08.12.2009)
Get more information
Journal Article
Improved quantification of angiogenesis in the rat aortic ring assay
BLACHER, Silvia, DEVY, Laetitia, BURBRIDGE, Mike F, ROLAND, Guy, TUCKER, Gordon, NOËL, Agnes, FOIDART, Jean-Michel
Published in Angiogenesis (London) (2001)
Published in Angiogenesis (London) (2001)
Get full text
Journal Article
Web Resource
Decrease in Survival Threshold of Quiescent Colon Carcinoma Cells in the Presence of a Small Molecule Integrin Antagonist
Burbridge, Mike F, Venot, Virginie, Casara, Patrick J, Perron-Sierra, Françoise, Hickman, John A, Tucker, Gordon C
Published in Molecular pharmacology (01.06.2003)
Published in Molecular pharmacology (01.06.2003)
Get full text
Journal Article
Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma
Massey, Andrew J., Benwell, Karen, Burbridge, Mike, Kotschy, Andras, Walmsley, David Lee
Published in Journal of cellular and molecular medicine (01.11.2021)
Published in Journal of cellular and molecular medicine (01.11.2021)
Get full text
Journal Article
First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours
Schöffski, Patrick, Awada, Ahmad, de la Bigne, Anne-Marie, Felloussi, Zakia, Burbridge, Mike, Cantero, Frederique, Colombo, Riccardo, Maruzzelli, Sara, Ammattatelli, Katia, de Jonge, Maja, Aftimos, Philippe, Dumez, Herlinde, Sleijfer, Stefan
Published in European journal of cancer (1990) (01.07.2022)
Published in European journal of cancer (1990) (01.07.2022)
Get full text
Journal Article
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
Lee Walmsley, David, Murray, James B, Dokurno, Pawel, Massey, Andrew J, Benwell, Karen, Fiumana, Andrea, Foloppe, Nicolas, Ray, Stuart, Smith, Julia, Surgenor, Allan E, Edmonds, Thomas, Demarles, Didier, Burbridge, Mike, Cruzalegui, Francisco, Kotschy, Andras, Hubbard, Roderick E
Published in Journal of medicinal chemistry (08.07.2021)
Published in Journal of medicinal chemistry (08.07.2021)
Get full text
Journal Article
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
Bertran-Alamillo, Jordi, Cattan, Valérie, Schoumacher, Marie, Codony-Servat, Jordi, Giménez-Capitán, Ana, Cantero, Frédérique, Burbridge, Mike, Rodríguez, Sonia, Teixidó, Cristina, Roman, Ruth, Castellví, Josep, García-Román, Silvia, Codony-Servat, Carles, Viteri, Santiago, Cardona, Andrés-Felipe, Karachaliou, Niki, Rosell, Rafael, Molina-Vila, Miguel-Angel
Published in Nature communications (18.04.2019)
Published in Nature communications (18.04.2019)
Get full text
Journal Article
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors
Weber, Csaba, Sipos, Melinda, Paczal, Attila, Balint, Balazs, Kun, Vilibald, Foloppe, Nicolas, Dokurno, Pawel, Massey, Andrew J, Walmsley, David Lee, Hubbard, Roderick E, Murray, James, Benwell, Karen, Edmonds, Thomas, Demarles, Didier, Bruno, Alain, Burbridge, Mike, Cruzalegui, Francisco, Kotschy, Andras
Published in Journal of medicinal chemistry (27.05.2021)
Published in Journal of medicinal chemistry (27.05.2021)
Get full text
Journal Article
Abstract 608: The MPS1 inhibitor S81694 is active in acute myeloid leukemia (AML)
Kaci, Anna, Adicéam, Emilie, De Braekeleer, Etienne, Garrido, Marine, Berrou, Jeannig, Dupont, Mélanie, Djamai, Hanane, Eclache, Virginie, André, Baruchel, Gardin, Claude, Dombret, Hervé, Burbridge, Mike, Braun, Thorsten
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Preclinical Activity of the MPS1 Inhibitor S81694 in Acute Lymphoblastic Leukemia (ALL)
Kaci, Anna, Adiceam, Emilie, Dupont, Melanie, Garrido, Marine, Berrou, Jeannig, Djamai, Hanane, Baruchel, Andre, Burbridge, Mike, Gardin, Claude, Dombret, Herve, Braun, Thorsten
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article